Literature DB >> 3219800

Demonstration of increased anti-mycobacterial activity in peripheral blood monocytes after BCG vaccination in British school children.

S H Cheng1, L Walker, J Poole, V R Aber, K B Walker, D A Mitchison, D B Lowrie.   

Abstract

A blood sample was taken from children aged 13-15 years immediately before BCG vaccination and 8 weeks after. The children were tuberculin skin-test negative to PPD-S before vaccination and positive after. Mononuclear cells were separated from the blood, infected with Mycobacterium microti at a low bacterium/monocyte ratio and allowed to form monolayers in microtitre wells. The infected monolayers were rinsed daily and the change in number of live bacteria in monolayers and supernatants was monitored by colony counts on agar. The cells were bacteriostatic during the first day, thereafter growth accelerated in pre-vaccination monolayers. When monolayers received pulsed exposures to autologous lymphocytes that had been incubated with whole dead tubercle bacilli the growth rates of M. microti were increased. However, growth rates in lymphocyte-pulsed monolayers were significantly lower after vaccination than before. It is proposed that this difference reflects the protective effect of vaccination.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3219800      PMCID: PMC1541699     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  13 in total

1.  Effect of macrocyclon in acute and chronic pulmonary tuberculous infection in mice as shown by viable and total bacterial counts.

Authors:  P D HART; R J REES
Journal:  Br J Exp Pathol       Date:  1960-08

2.  Activation of macrophages to inhibit proliferation of Mycobacterium tuberculosis: comparison of the effects of recombinant gamma-interferon on human monocytes and murine peritoneal macrophages.

Authors:  G A Rook; J Steele; M Ainsworth; B R Champion
Journal:  Immunology       Date:  1986-11       Impact factor: 7.397

Review 3.  Macrophage antimycobacterial mechanisms.

Authors:  D B Lowrie; P W Andrew
Journal:  Br Med Bull       Date:  1988-07       Impact factor: 4.291

4.  Conditions for production, and some characteristics, of mycobacterial growth inhibitory factor produced by spleen cells from mice immunized with viable cells of the attenuated H37Ra strain of Mycobacterium tuberculosis.

Authors:  D L Cahall; G P Youmans
Journal:  Infect Immun       Date:  1975-10       Impact factor: 3.441

5.  Effectiveness of BCG vaccination in England and Wales in 1983.

Authors:  I Sutherland; V H Springett
Journal:  Tubercle       Date:  1987-06

6.  Lymphocyte-mediated modification of blood-derived macrophage function in vitro; inhibition of growth of intracellular mycobacteria with lymphokines.

Authors:  T Godal; R J Rees; J O Lamvik
Journal:  Clin Exp Immunol       Date:  1971-04       Impact factor: 4.330

7.  Killing of Mycobacterium microti by immunologically activated macrophages.

Authors:  L Walker; D B Lowrie
Journal:  Nature       Date:  1981-09-03       Impact factor: 49.962

8.  Natural mycobacteriostatic activity in human monocyte-derived adherent cells.

Authors:  G S Douvas; E M Berger; J E Repine; A J Crowle
Journal:  Am Rev Respir Dis       Date:  1986-07

9.  Mycobacterial growth inhibition by interferon-gamma-activated bone marrow macrophages and differential susceptibility among strains of Mycobacterium tuberculosis.

Authors:  I Flesch; S H Kaufmann
Journal:  J Immunol       Date:  1987-06-15       Impact factor: 5.422

10.  Gamma interferon activates human macrophages to become tumoricidal and leishmanicidal but enhances replication of macrophage-associated mycobacteria.

Authors:  G S Douvas; D L Looker; A E Vatter; A J Crowle
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

View more
  8 in total

1.  Bactericidal activity in whole blood as a potential surrogate marker of immunity after vaccination against tuberculosis.

Authors:  Seon-Hee Cheon; Beate Kampmann; Amy G Hise; Manijeh Phillips; Ho-Yeon Song; Katherine Landen; Qing Li; Rhonda Larkin; Jerrold J Ellner; Richard F Silver; Daniel F Hoft; Robert S Wallis
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

2.  The pattern of mycobacterial antigen recognition in sera from Mantoux-negative individuals is essentially unaffected by bacille Calmette-Guérin (BCG) vaccination in either south India or London.

Authors:  S Das; S H Cheng; D B Lowrie; K B Walker; D A Mitchison; R S Vallishayee; P R Narayanan
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

Review 3.  Is macrophage death on the field of battle essential to victory, or a tactical weakness in immunity against tuberculosis?

Authors:  D B Lowrie
Journal:  Clin Exp Immunol       Date:  1990-06       Impact factor: 4.330

4.  Monocyte antimycobacterial activity before and after Mycobacterium bovis BCG vaccination in Chingleput, India, and London, United Kingdom.

Authors:  S H Cheng; K B Walker; D B Lowrie; D A Mitchison; R Swamy; M Datta; R Prabhakar
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

5.  Strain specificity of antimycobacterial immunity in whole blood culture after cure of tuberculosis.

Authors:  Robert S Wallis; Solange Vinhas; Ernestas Janulionis
Journal:  Tuberculosis (Edinb)       Date:  2009-03-24       Impact factor: 3.131

6.  A functional whole blood assay to measure viability of mycobacteria, using reporter-gene tagged BCG or M.Tb (BCGlux/M.Tb lux).

Authors:  Sandra Newton; Adrian Martineau; Beate Kampmann
Journal:  J Vis Exp       Date:  2011-09-14       Impact factor: 1.355

7.  A non-human primate in vitro functional assay for the early evaluation of TB vaccine candidates.

Authors:  Rachel Tanner; Andrew D White; Charelle Boot; Claudia C Sombroek; Matthew K O'Shea; Daniel Wright; Emily Hoogkamer; Julia Bitencourt; Stephanie A Harris; Charlotte Sarfas; Rachel Wittenberg; Iman Satti; Helen A Fletcher; Frank A W Verreck; Sally A Sharpe; Helen McShane
Journal:  NPJ Vaccines       Date:  2021-01-04       Impact factor: 7.344

8.  Application of a whole blood mycobacterial growth inhibition assay to study immunity against Mycobacterium tuberculosis in a high tuberculosis burden population.

Authors:  Richard Baguma; Adam Penn-Nicholson; Erica Smit; Mzwandile Erasmus; Jonathan Day; Lebohang Makhethe; Marwou de Kock; E Jane Hughes; Michele van Rooyen; Bernadette Pienaar; Lynnett Stone; Willem Hanekom; Michael J Brennan; Robert S Wallis; Mark Hatherill; Thomas J Scriba
Journal:  PLoS One       Date:  2017-09-08       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.